Contego Medical Announces One-Year Outcomes From the Performance II Carotid Stent Trial lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Contego Medical Inc. announced the presentation of late-breaking clinical results from the PERFORMANCE II carotid stent trial at the annual VIVA (Vascular InterVentional Advances), VIVA 23, being held Oct. 30-Nov. 2 in Las Vegas, NV. The PERFORMANCE II is a prospective, multicenter study evaluating the safety and effectiveness of the Neuroguard IEP System in 305 patients at 40 clinical sites.
On July 11, 2023, the U.S. Food and Drug Administration published a letter to healthcare providers stating that, based on its review of the totality of the available data and analyses,.
Medical device startup Contego Medical continues to generate traction with investors, raising nearly $23 million in a fourth round of financing, according to an SEC filing.